NDC 60763-482 - GLYCOPYRROLATE
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 60763-482
- Package NDCs from labels
- 60763-482-02
- Manufacturer
- Stason Pharmaceuticals | Stason Pharmaceuticals, Inc. | Contract Pharmacal Corp.
- Effective date
- 2021-12-13
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| GLYCOPYRROLATE TABLETS USP 1 mg and 2 mg Rx only | Stason Pharmaceuticals | Stason Pharmaceuticals, Inc. | Contract Pharmacal Corp. | 2021-12-13 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 60763-482-02 | 2025-02-17 | C162847 | 48780-1 | f386c64a-19ba-0266-e053-dadaa90a7c1a | GLYCOPYRROLATE TABLETS USP 1 mg and 2 mg Rx only |
| 60763-482-02 | 2023-01-30 | C162847 | 48780-1 | f386c64a-19ba-0266-e053-dadaa90a7c1a | GLYCOPYRROLATE TABLETS USP 1 mg and 2 mg Rx only |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Glycopyrrolate | GLYCOPYRROLATE | American Regent, Inc. | 62267afe-1a73-4623-984e-646db590ec5b | 2024-02-07 | Warnings, Adverse reactions | V92SO9WP2I |
| GLYCOPYRROLATE | GLYCOPYRROLATE | HF Acquisition Co LLC, DBA HealthFirst | c4c3be3a-ea28-864f-e053-2a95a90a701a | 2024-01-30 | Warnings, Adverse reactions | V92SO9WP2I |
| GLYCOPYRROLATE | GLYCOPYRROLATE | HF Acquisition Co LLC, DBA HealthFirst | e76bc0e4-68f5-70b4-e053-2a95a90a451e | 2024-01-22 | Warnings, Adverse reactions | V92SO9WP2I |
| Glycopyrrolate | GLYCOPYRROLATE | Bryant Ranch Prepack | 579d2499-6520-41fb-ae52-f3d8b9af8950 | 2024-01-12 | Warnings, Adverse reactions | V92SO9WP2I |
| Glycopyrrolate | GLYCOPYRROLATE | NorthStar RxLLC | ed22456b-b488-49ec-b96b-2541f5f3c955 | 2024-01-10 | Warnings, Adverse reactions | V92SO9WP2I |
| GLYCOPYRROLATE | GLYCOPYRROLATE | FH2 Pharma LLC | 18ca98ed-522d-470f-bb22-908bbd7d489a | 2023-12-31 | Warnings, Adverse reactions | V92SO9WP2I |
| Glycopyrrolate | GLYCOPYRROLATE | Medical Purchasing Solutions, LLC | 0933e843-df2a-3d32-e063-6394a90a1037 | 2023-11-02 | Warnings, Adverse reactions | V92SO9WP2I |
| GLYCOPYRROLATE 1ML | GLYCOPYRROLATE | XIROMED LLC | 1bb2fa8a-3318-1e9a-2c79-8371bcae3d1c | 2023-10-23 | Warnings, Adverse reactions | V92SO9WP2I |
| Glycopyrrolate | GLYCOPYRROLATE | Fresenius Kabi USA, LLC | 250eeef7-b1a9-45e7-a927-7807232e10be | 2023-09-22 | Warnings, Adverse reactions | V92SO9WP2I |
| Glycopyrrolate | GLYCOPYRROLATE | Fresenius Kabi USA, LLC | 54458620-d888-4df6-ae4b-78c3dfed3423 | 2023-08-16 | Warnings, Adverse reactions | V92SO9WP2I |
| Glycopyrrolate | GLYCOPYRROLATE | Fresenius Kabi USA, LLC | 88d3e865-8dca-4c89-b6f7-a34c481f75b9 | 2023-08-16 | Warnings, Adverse reactions | V92SO9WP2I |
| GLYCOPYRROLATE | GLYCOPYRROLATE | Bryant Ranch Prepack | 4c733750-45fe-4876-8e4f-c61c52470405 | 2023-06-06 | Warnings, Adverse reactions | V92SO9WP2I |
| Glycopyrrolate | GLYCOPYRROLATE | Medical Purchasing Solutions, LLC | 86abf577-562c-5eb1-e053-2a91aa0ac10f | 2023-06-01 | Warnings, Adverse reactions | V92SO9WP2I |
| Glycopyrrolate | GLYCOPYRROLATE | Medical Purchasing Solutions, LLC | 66726c2b-27e8-5dd1-e053-2991aa0a1ba7 | 2023-06-01 | Warnings, Adverse reactions | V92SO9WP2I |
| Glycopyrrolate | GLYCOPYRROLATE | Medical Purchasing Solutions, LLC | 69353cc1-f5d4-170b-e053-2a91aa0ad5a5 | 2023-05-23 | Warnings, Adverse reactions | V92SO9WP2I |
| Glycopyrrolate | GLYCOPYRROLATE | Medical Purchasing Solutions, LLC | 6934f467-949f-97cc-e053-2a91aa0a05fb | 2023-05-23 | Warnings, Adverse reactions | V92SO9WP2I |
| Glycopyrrolate | GLYCOPYRROLATE | Medical Purchasing Solutions, LLC | 95fbe384-eaff-1f2e-e053-2a95a90a0313 | 2023-05-15 | Warnings, Adverse reactions | V92SO9WP2I |
| Glycopyrrolate | GLYCOPYRROLATE | Medical Purchasing Solutions, LLC | 8f126596-7fbf-7a48-e053-2995a90abac7 | 2023-05-15 | Warnings, Adverse reactions | V92SO9WP2I |
| Glycopyrrolate | GLYCOPYRROLATE | Medical Purchasing Solutions, LLC | 8f12016d-9033-00b4-e053-2a95a90ad02a | 2023-05-15 | Warnings, Adverse reactions | V92SO9WP2I |
| Glycopyrrolate | GLYCOPYRROLATE | Medical Purchasing Solutions, LLC | 9c9666bf-841b-03fa-e053-2a95a90abb48 | 2023-05-11 | Warnings, Adverse reactions | V92SO9WP2I |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.